Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies-Reference-Cited by-同舟云学术

Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies

Published:2022-12-02 Issue:3 Volume:16 Page:383-397
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Izmailova Elena S.¹^ORCID,Maguire R. Paul²^ORCID,McCarthy Timothy J.³,Müller Martijn L. T. M.⁴,Murphy Philip⁵,Stephenson Diane⁴

Affiliation:

1. Koneksa Health New York New York USA

2. UCB Biopharma SRL Braine l'Alleud Belgium

3. Pfizer Early Clinical Development Massachusetts Cambridge USA

4. Critical Path Institute Tucson Arizona USA

5. Janssen Research and Development High Wycombe UK

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13461

Reference88 articles.

1. How to improve R&D productivity: the pharmaceutical industry's grand challenge

2. Critical Path Initiative. Accessed November 30 2022.https://www.fda.gov/science‐research/science‐and‐research‐special‐topics/critical‐path‐initiative

3. Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape

4. The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders

5. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-06-25

2. Measuring gait parameters from a single chest-worn accelerometer in healthy individuals: a validation study;Scientific Reports;2024-06-17

3. Empowering rheumatology through digital health technologies: contributions and barriers;Exploration of Musculoskeletal Diseases;2024-04-09

4. A proposed multi‐domain, digital model for capturing functional status and health‐related quality of life in oncology;Clinical and Translational Science;2024-01

5. Predicting the pharmacokinetics and pharmacodynamics of antisense oligonucleotides: an overview of various approaches and opportunities for PBPK/PD modelling;Expert Opinion on Drug Metabolism & Toxicology;2023-11-18